article · Discover Public Health
Anaemia remains a major comorbidity among children living with HIV (CLHIV) in sub-Saharan Africa, yet sex-specific risk factors are poorly characterized. This study investigated the prevalence and sex-based determinants of anaemia among CLHIV in the Southern Province, Zambia. A retrospective cross-sectional study was conducted using medical records from 321 CLHIV aged 0–14 years. Data on demographic, clinical, and anthropometric variables were analysed. Sex-stratified multivariable logistic regression identified factors associated with anaemia (Hb < 10.9 g/dL). Overall anaemia prevalence was 47.0% (151/321), with a higher, though not statistically significant, burden in males (52.6%) than females (41.9%). Younger age was a strong, independent risk factor across both sexes. Distinct sex-specific determinants were identified. In males, no statistically significant association between CTX use and anaemia was observed (Adjusted Odds Ratio, AOR = 3.04; 95% CI: 0.95–9.74). Care provided by an aunt was significantly associated with lower odds of anaemia compared to other caregiving arrangement (AOR = 0.10; 95% CI: 0.01–0.90). Poor anthropometric indices (height and weight) were significantly associated with anaemia in both sexes. The study findings reveal a high prevalence of anaemia among CLHIV in Zambia, with nuanced sex-based differences in its determinants. The findings advocate for differentiated, gender-sensitive intervention strategies. For boys, careful review of CTX prophylaxis is warranted, while for girls, enhancing supportive caregiving environments may be protective. Integrating these sex-specific approaches into paediatric HIV programs is crucial for reducing the anaemia burden and improving clinical outcomes.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1186/s12982-026-01771-y
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.